Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Collegium Pharmaceutical, Inc. (COLL) had Cost of Goods Sold of $89.59M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$199.88M |
|
$-15.05M |
|
|
Cost of Goods Sold |
$89.59M |
$110.29M |
|
$196.18M |
|
$3.70M |
|
$-17.23M |
|
$-13.53M |
|
$-13.53M |
|
$-15.05M |
|
$-15.05M |
|
$-15.05M |
|
$-15.05M |
|
$3.70M |
|
$68.42M |
|
32.46M |
|
32.46M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$608.01M |
|
$10.65M |
|
$1.53B |
|
$2.14B |
|
$589.86M |
|
$1.04B |
|
$1.23B |
|
$1.82B |
|
$311.91M |
|
$-1.06B |
|
$311.91M |
|
32.50M |
|
| Cash Flow Statement Financials | |
$128.44M |
|
$-500.96M |
|
$270.75M |
|
$252.16M |
|
$150.38M |
|
$-101.78M |
|
$25.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.03 |
|
-- |
|
-- |
|
0.77 |
|
3.50 |
|
55.18% |
|
1.85% |
|
1.85% |
|
-- |
|
-6.77% |
|
-7.53% |
|
$127.67M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.79 |
|
0.70 |
|
128.37 |
|
-4.83% |
|
1.41% |
|
-0.70% |
|
-1.12% |
|
$9.60 |
|
$3.93 |
|
$3.96 |
|